Anti-ANO1/ ANO/ DOG1 monoclonal antibody

Anti-ANO1/ ANO/ DOG1 antibody for FACS & in-vivo assay

Target products collectionGo to ANO/ANO1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T05089-Ab-1/ GM-Tg-hg-T05089-Ab-2Anti-Human ANO/ANO1 monoclonal antibodyHuman
GM-Tg-rg-T05089-Ab-1/ GM-Tg-rg-T05089-Ab-2Anti-Rat ANO/ANO1 monoclonal antibodyRat
GM-Tg-mg-T05089-Ab-1/ GM-Tg-mg-T05089-Ab-2Anti-Mouse ANO/ANO1 monoclonal antibodyMouse
GM-Tg-cynog-T05089-Ab-1/ GM-Tg-cynog-T05089-Ab-2Anti-Cynomolgus/ Rhesus macaque ANO/ANO1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T05089-Ab-1/ GM-Tg-felg-T05089-Ab-2Anti-Feline ANO/ANO1 monoclonal antibodyFeline
GM-Tg-cang-T05089-Ab-1/ GM-Tg-cang-T05089-Ab-2Anti-Canine ANO/ANO1 monoclonal antibodyCanine
GM-Tg-bovg-T05089-Ab-1/ GM-Tg-bovg-T05089-Ab-2Anti-Bovine ANO/ANO1 monoclonal antibodyBovine
GM-Tg-equg-T05089-Ab-1/ GM-Tg-equg-T05089-Ab-2Anti-Equine ANO/ANO1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T05089-Ab-1/ GM-Tg-hg-T05089-Ab-2; GM-Tg-rg-T05089-Ab-1/ GM-Tg-rg-T05089-Ab-2;
GM-Tg-mg-T05089-Ab-1/ GM-Tg-mg-T05089-Ab-2; GM-Tg-cynog-T05089-Ab-1/ GM-Tg-cynog-T05089-Ab-2;
GM-Tg-felg-T05089-Ab-1/ GM-Tg-felg-T05089-Ab-2; GM-Tg-cang-T05089-Ab-1/ GM-Tg-cang-T05089-Ab-2;
GM-Tg-bovg-T05089-Ab-1/ GM-Tg-bovg-T05089-Ab-2; GM-Tg-equg-T05089-Ab-1/ GM-Tg-equg-T05089-Ab-2
Products NameAnti-ANO/ANO1 monoclonal antibody
Formatmab
Target NameANO
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ANO benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species ANO1/ ANO/ DOG1 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP002834human ANO1 Lentivirus plasmid
    ORF Viral VectorvGMLP002834human ANO1 Lentivirus particle
    ORF Viral VectorpGMLV000700zebrafish ano1 Lentivirus plasmid
    ORF Viral VectorvGMLV000700zebrafish ano1 Lentivirus particle


    Target information

    Target IDGM-T05089
    Target NameANO
    Gene ID55107,101772,309135,708723,611698,101087608,532126,100061836
    Gene Symbol and SynonymsANO1,DOG1,INDMS,ORAOV2,TAOS2,™EM16A
    Uniprot AccessionQ5XXA6
    Uniprot Entry NameANO1_HUMAN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseBreast Cancer
    Gene EnsemblENSG00000131620
    Target ClassificationN/A

    The target: ANO, gene name: ANO1, also named as DOG1, ORAOV2, TAOS2, ™EM16A. Enables calcium activated cation channel activity; intracellular calcium activated chloride channel activity; and iodide transmembrane transporter activity. Involved in cation transport; inorganic anion transport; and positive regulation of insulin secretion involved in cellular response to glucose stimulus. Located in apical plasma membrane and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.